Neumora Therapeutics, Inc. Common StockNMRANASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-263.46M
↓ 43% below average
Average (4y)
$-184.07M
Historical baseline
Range
High:$-95.52M
Low:$-263.46M
CAGR
+28.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-263.46M | -40.0% |
| 2023 | $-188.19M | -38.5% |
| 2022 | $-135.87M | +42.7% |
| 2021 | $-237.32M | -148.5% |
| 2020 | $-95.52M | - |